An Important Step Forward in Precision Oncology: New Genetic Tool Predicts Chemotherapy Side Effects Before Treatment Begins
1 Articles
1 Articles
An Important Step Forward in Precision Oncology: New Genetic Tool Predicts Chemotherapy Side Effects Before Treatment Begins
Newswise — Philadelphia, 24th February 2024 – A groundbreaking pharmacogenetic tool has been developed and validated to predict chemotherapy side effects based on a patient’s genetic profile. This innovative platform, tested in patients with non-small-cell lung cancer (NSCLC), could revolutionize cancer treatment and extend beyond oncology, allowing anyone to assess their genetic predisposition to chemotherapy-related toxicity before ever develo…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage